Skip to main content
logo
SinoMab BioScience Limited (HKG:3681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.360
0.00 (0.00%)
Jul 31, 2026, 4:08 PM HKT

SinoMab BioScience Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--2.031.374.0326.66
Revenue Growth
--48.43%-66.15%-84.88%108.91%
Gross Profit
--0.540.424.0326.66
Operating Income
-128.01-128.01-161.93-232.6-258.93-305.86
Net Income
-104.99-104.99-185.14-243.11-284.16-288.19
Earnings Per Share
-0.09-0.09-0.17-0.24-0.29-0.29
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
377.25377.25110.77237.53422.39589.53
Total Debt
338.49338.49482.27450.81357.18275.46
Net Cash (Debt)
38.7638.76-371.5-213.2865.2314.07
Net Cash Growth
-----79.24%-61.62%
Net Cash Per Share
0.030.03-0.35-0.210.070.32

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-70.48-70.48-130.8-133.85-300.54-147.06
Capital Expenditures
-25.03-25.03-41.17-103.34-112.75-198.23
Free Cash Flow
-95.5-95.5-171.97-237.19-413.29-345.3
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--26.80%30.92%100.00%100.00%
Operating Margin
---7992.40%-17040.44%-6421.80%-1147.38%
Pretax Margin
---9138.25%-17810.33%-7047.57%-1081.12%
Profit Margin
---9138.25%-17810.33%-7047.57%-1081.12%
FCF Margin
---8487.96%-17376.19%-10250.22%-1295.33%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--551.951156.20410.9587.95